Alx Oncology Holdings (ALXO) Interest & Investment Income (2020 - 2026)
Alx Oncology Holdings recorded quarterly Interest & Investment Income of $1.2 million in Q1 2026, up 106.28% quarter-over-quarter from $573000.0 in Q4 2025, and down 20.3% year-over-year from $1.5 million in Q1 2025.
Alx Oncology Holdings' Interest & Investment Income history runs 7 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 20.3% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $3.7 million (down 55.48% YoY), while the FY2025 annual figure was $4.0 million, down 57.68% from the prior year.
- Interest & Investment Income came in at $1.2 million for Q1 2026 at Alx Oncology Holdings, up from $573000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $3.0 million in Q4 2023 to a low of $225000.0 in Q1 2022.
- A 5-year average of $1.7 million and a median of $1.8 million in 2022 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income surged 8504.76% in 2022 and sank 69.49% in 2025, its largest moves.
- Alx Oncology Holdings' Interest & Investment Income stood at $1.8 million in 2022, then surged by 65.74% to $3.0 million in 2023, then slumped by 37.3% to $1.9 million in 2024, then tumbled by 69.49% to $573000.0 in 2025, then jumped by 106.28% to $1.2 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $1.2 million, $573000.0, and $802000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.18 Mn |
| Dec 31, 2025 | 573,000.00 |
| Sep 30, 2025 | 802,000.00 |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 1.88 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 2.56 Mn |
| Mar 31, 2024 | 2.62 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 2.68 Mn |
| Jun 30, 2023 | 2.67 Mn |
| Mar 31, 2023 | 2.31 Mn |
| Dec 31, 2022 | 1.81 Mn |
| Sep 30, 2022 | 1.37 Mn |
| Jun 30, 2022 | 876,000.00 |
| Mar 31, 2022 | 225,000.00 |
| Dec 31, 2021 | 21,000.00 |
| Sep 30, 2021 | 22,000.00 |
| Jun 30, 2021 | 23,000.00 |
| Mar 31, 2021 | 25,000.00 |
| Dec 31, 2020 | 784,000.00 |
| Sep 30, 2020 | -226,000.00 |
| Jun 30, 2020 | -219,000.00 |
| Mar 31, 2020 | -215,000.00 |